Valuation Diagnostic and Therapeutic Center of Athens HYGEIA SA
Stocks
HYGEIA
GRS445003007
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
Company Valuation: Diagnostic and Therapeutic Center of Athens HYGEIA SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 290.4 | 290.4 | 290.4 | 290.4 | 290.4 | 290.4 |
| Change | - | 0% | 0% | 0% | 0% | 0% |
| Enterprise Value (EV) 1 | 336.1 | 478.8 | 447.6 | 437.1 | 411.2 | 398.3 |
| Change | - | 42.45% | -6.5% | -2.36% | -5.93% | -3.12% |
| P/E Ratio | 8.64x | - | 7.24x | 0x | 0x | 0.01x |
| PBR | 1.65x | - | 0.75x | 0x | 0x | 0x |
| PEG | - | - | - | - | - | -0x |
| Capitalization / Revenue | 2.03x | 2.06x | 1.92x | 1.81x | 1.69x | 1.64x |
| EV / Revenue | 2.35x | 3.4x | 2.96x | 2.72x | 2.39x | 2.24x |
| EV / EBITDA | 8.98x | 12.6x | 11x | 9.58x | 8.64x | 8.16x |
| EV / EBIT | 10.6x | 14.9x | 14x | 12.1x | 10.8x | 10.9x |
| EV / FCF | 18.7x | 39.7x | 13.6x | -3.01x | 12.6x | 26.9x |
| FCF Yield | 5.35% | 2.52% | 7.34% | -33.3% | 7.97% | 3.72% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.11 | - | 0.1311 | 558.7 | 251.6 | 152.5 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 143.1 | 140.8 | 151 | 160.6 | 172 | 177.5 |
| EBITDA 1 | 37.41 | 38.08 | 40.64 | 45.61 | 47.59 | 48.82 |
| EBIT 1 | 31.58 | 32.17 | 32.06 | 36.08 | 38.16 | 36.53 |
| Net income 1 | 33.63 | 22.4 | 23.3 | 55.87 | 25.16 | 15.25 |
| Net Debt 1 | 45.65 | 188.3 | 157.2 | 146.6 | 120.7 | 107.9 |
| Reference price 2 | 0.9500 | 0.9500 | 0.9500 | 0.9500 | 0.9500 | 0.9500 |
| Nbr of stocks (in thousands) | 305,732 | 305,732 | 305,732 | 305,732 | 305,732 | 305,732 |
| Announcement Date | 4/15/20 | 6/24/22 | 6/24/22 | 5/22/23 | 5/23/24 | 6/18/25 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 0 | ||
| 15.72x | 0.44x | 9.55x | 2.69% | 125B | ||
| 12.36x | 1.64x | 8.12x | 0.83% | 82.82B | ||
| 11.26x | 1.34x | 8.09x | 3.01% | 24.53B | ||
| 21.16x | 2.32x | 11.72x | 1.57% | 22.56B | ||
| 29.11x | 5.3x | 22.22x | 2.43% | 20.01B | ||
| 6.54x | 1.12x | 5.27x | -.--% | 14.19B | ||
| 14.47x | 1.37x | 6.99x | 4.85% | 13.82B | ||
| 13.54x | 1.67x | 8.03x | 0.84% | 12.75B | ||
| 12.74x | 0.99x | 5.54x | 3.57% | 12.05B | ||
| Average | 15.21x | 1.80x | 9.50x | 2.2% | 32.78B | |
| Weighted average by Cap. | 15.08x | 1.38x | 9.50x | 2.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- HYGEIA Stock
- Valuation Diagnostic and Therapeutic Center of Athens HYGEIA SA
Select your edition
All financial news and data tailored to specific country editions
















